Use of immunohistochemical biomarkers as independent predictor of neoplastic progression in Barrett's oesophagus surveillance: A systematic review and meta-analysis

por Janmaat, Vincent T., van Olphen, Sophie H., Biermann, Katharina E., Looijenga, Leendert H. J., Bruno, Marco B., Spaander, Manon C. W.
Publicado 2017

Loss of SRY‐box2 (SOX2) expression and its impact on survival of patients with oesophageal adenocarcinoma

por ten Kate, F. J. C., van Olphen, S. H., Bruno, M. J., Wijnhoven, B. P. L., van Lanschot, J. J. B., Looijenga, L. H. J., Fitzgerald, R. C., Biermann, K.
Publicado 2017

Value of cyclin A immunohistochemistry for cancer risk stratification in Barrett esophagus surveillance: A multicenter case–control study

por van Olphen, Sophie H., ten Kate, Fiebo J.C., Doukas, Michail, Kastelein, Florine, Steyerberg, Ewout W., Stoop, Hans A., Spaander, Manon C., Looijenga, Leendert H.J., Bruno, Marco J., Biermann, Katharina
Publicado 2016